PLN-75068

N/A

Report date: 2022/07/25 17:14:04
NME

Base Information

Drug NamePLN-75068
Drug Alias NamePLN-75068
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-V/beta-1 inhibitorsIntegrin alpha-V/beta-6 antagonists
TargetsIntegrin alpha-V/beta-1Integrin alpha-V/beta-6
Therapy Area/IndicationsLiver CirrhosisHypertension, Portal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPliant Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesPliant Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsLiver CirrhosisHypertension, Portal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A